Concepedia

Mark Barakat

MB

Statistics

Publications

31

Citations

1.4K

H-Index

18

Active since

2002

Affiliations

Retina Consultants of Texas(Current)

Retinal Consultants of Arizona

Clearside Biomedical (United States)

Retina Vitreous Associates of Florida

Texas Retina Associates (United States)

Mark Barakat is an author at Retina Consultants of Texas specializing in medicine, ophthalmology, and ocular pharmacology.

ORCID

Publications per year

2002–2024

31

Publications

31

The nuclear receptor <i>NR2E3</i> plays a role in human retinal photoreceptor differentiation and degeneration

Ann H. Milam, Linda Rose, Artur V. Cideciyan et al. · Proceedings of the National Academy of Sciences · 2002 · 239 citations

, , +17

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

Arshad M. Khanani, Aamir Aziz, Hannah Khan et al. · Eye · 2023 · 167 citations · Full text

, , +8

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 138 citations · Full text

, , +9

Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study

Peter A. Campochiaro, Charles C. Wykoff, David M. Brown et al. · Ophthalmology Retina · 2017 · 113 citations

, , +6

Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema

Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina · 2020 · 58 citations · Full text

, , +17

1–5 of 31